ATP2B1-AS1: A Potential Drug Target and Biomarker for Analyzing Cellular Functions

Target Name: ATP2B1-AS1

NCBI ID: G338758

ATP2B1-AS1

Other Name(s): ATP2B1 antisense RNA 1 | LINC00936

ATP2B1-AS1: A Potential Drug Target and Biomarker for Analyzing Cellular Functions

ATP (adenylyl cyclic phosphate) is a crucial energy source for all living cells. It is involved in various cellular processes, including muscle contractions, protein synthesis, and chromatin regulation. ATP is generated fromADP (adenylyl cyclic phosphate) by the process of phosphorylation. Phosphorylation is the addition of a phosphate group to a specific amino acid residue, resulting in a change in activity. ATP is widely used in cellular signaling pathways, including those involved in cell growth, differentiation, and apoptosis.

The ATPase enzyme is a key component of many cellular processes. It is responsible for generating ATP from ADP through a phosphate-protein-inactivating mechanism. The ATPase enzyme has two subunits, ATP2B1 and ATP2B2. In recent years, researchers have discovered that ATP2B1 plays a critical role in cellular signaling pathways. ATP2B1 is also known as ATP2B1-AS1 (ATP2B1 antisense RNA 1).

ATP2B1-AS1: A Putative Drug Target

The identification of ATP2B1-AS1 as a potential drug target is based on its involvement in cellular signaling pathways. ATP2B1 is involved in the production of ATP, which is a critical energy source for cellular processes. Therefore, inhibiting ATP2B1 activity could potentially lead to a decrease in cellular ATP production and disrupt cellular signaling pathways.

ATP2B1-AS1 has been shown to play a role in various cellular signaling pathways, including the regulation of cell adhesion, the production of neurotransmitters, and the regulation of cellular signaling pathways involved in cell growth and apoptosis. For example, studies have shown that ATP2B1-AS1 can promote the production of tight junctions, which are a type of cell-cell adhesion barrier. Additionally, ATP2B1-AS1 has been shown to play a role in the production of neurotransmitters, such as dopamine and serotonin.

Furthermore, studies have shown that ATP2B1-AS1 can also regulate cellular signaling pathways involved in cell growth and apoptosis. For example, ATP2B1-AS1 has been shown to promote the production of apoptosis-associated protein (AP-1), which is involved in the regulation of cell apoptosis. Additionally, ATP2B1-AS1 has been shown to promote the production of Badp7, which is involved in the regulation of cell apoptosis.

The potential drug target for ATP2B1-AS1 is based on its involvement in cellular signaling pathways. By inhibiting ATP2B1-AS1 activity, researchers hope to disrupt cellular signaling pathways and potentially lead to a range of cellular consequences, including the inhibition of cell growth, apoptosis, and neurotransmission.

ATP2B1-AS1: A Potential Biomarker

The identification of ATP2B1-AS1 as a potential drug target also suggests that it may be a useful biomarker for tracking the effectiveness of certain therapies. By measuring the levels of ATP2B1-AS1 in cells, researchers can potentially determine the effectiveness of drugs that target ATP2B1-AS1.

ATP2B1-AS1 is a gene that encodes for a protein known as AS1. AS1 is a negative regulator of the ATPase enzyme, which means that it works to prevent the activity of the ATPase enzyme. Inactive AS1 can be used as a biomarker for tracking the effects of drugs that target the ATP

Protein Name: ATP2B1 Antisense RNA 1

The "ATP2B1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP2B1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets